The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $804,075 in first-year total cost, median $402,038.
Most frequent study sections
- Special Emphasis Panel[ZDA1 SUY-S (M2)]2
Most frequent institutions
- ALTRUMED LLC1
- ARUNA BIOMEDICAL, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Device-Agnostic Hypoxia Detection Software for Overdose Prediction and Positive Reversal Monitoring1R43DA064271-01 | LINGAMOORTHY, ANUSHONI, OLUMUYIWA | ALTRUMED LLC, PA | $404,078 | ZDA1 |
| 2025 | Neural exosome therapeutics for treating opioid-induced brain hypoxia injuries1R43DA064200-01 | BAKER, EMILY W | ARUNA BIOMEDICAL, INC., GA | $399,997 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.